Search Results
Aug 14, 2026, 13:52 ET DeFi Technologies Inc. gibt die Finanzergebnisse für das zweite Quartal 2026 bekannt: Umsatz von 7,8 Mio. USD, operativer Verlust von 2,3 Mio. USD und weiterhin solide Bilanz
USDT/USDC, was einem Gesamtguthaben von 70.664.075 USD entspricht.Saldo STRC/RWUSD: Zum 30. Juni 2026 hielt das Unternehmen 19.050.483 USD in STRC/RWUSD. Bestände an digitalen Vermögenswerten: Zum 30. Juni 2026 beliefen sich die eigenen
More news about: DeFi Technologies Inc.
Aug 13, 2026, 17:15 ET DeFi Technologies Inc. Announces Second Quarter 2026 Financial Results with Revenue of $7.8 Million, Operating Loss of $2.3 Million, and Maintained Strong Balance Sheet
$10,352,363 in USDT/USDC, for a combined balance of $70,664,075STRC/RWUSD balance: As of June 30, 2026, the Company held $19,050,483 in STRC/RWUSD. Digital asset treasury holdings: As of June 30, 2026, the Company's treasury holdings
More news about: DeFi Technologies Inc.
Aug 13, 2026, 17:15 ET DeFi Technologies Inc. Announces Second Quarter 2026 Financial Results with Revenue of $7.8 Million, Operating Loss of $2.3 Million, and Maintained Strong Balance Sheet
$10,352,363 in USDT/USDC, for a combined balance of $70,664,075STRC/RWUSD balance: As of June 30, 2026, the Company held $19,050,483 in STRC/RWUSD. Digital asset treasury holdings: As of June 30, 2026, the Company's
More news about: DeFi Technologies Inc.
Jun 30, 2026, 10:27 ET Rescue Hearing Inc. Marks Major Milestone as MED-EL Acquires Two Gene Therapy Programs Targeting Genetic Hearing Loss and Balance Disorders
MED-EL acquires Rescue Hearing's MYO7A and STRC gene therapy programs for genetic hearing and balance disorders. The MYO7A gene therapy program is being developed to address a genetic cause of balance disorders, while the STRC gene therapy program targets a genetic cause of hearing
More news about: Rescue Hearing Inc.